Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis

BACKGROUND: An updated economic evaluation was conducted to compare the cost-effectiveness of the four tumour necrosis factor (TNF)-α inhibitors adalimumab, etanercept, golimumab and infliximab in active, progressive psoriatic arthritis (PsA) where response to standard treatment has been inadequate....

Descripción completa

Detalles Bibliográficos
Autores principales: Cawson, Matthew Richard, Mitchell, Stephen Andrew, Knight, Chris, Wildey, Henry, Spurden, Dean, Bird, Alex, Orme, Michelle Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903562/
https://www.ncbi.nlm.nih.gov/pubmed/24444034
http://dx.doi.org/10.1186/1471-2474-15-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903562/
https://www.ncbi.nlm.nih.gov/pubmed/24444034
http://dx.doi.org/10.1186/1471-2474-15-26

Ejemplares similares